These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27252269)
41. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. von Scheven E; Glidden DV; Elder ME Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489 [TBL] [Abstract][Full Text] [Related]
42. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]
43. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]. Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643 [TBL] [Abstract][Full Text] [Related]
44. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome. Galli M Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065 [TBL] [Abstract][Full Text] [Related]
45. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β Elbagir S; Mohammed NA; Kaihola H; Svenungsson E; Gunnarsson I; Manivel VA; Pertsinidou E; Elagib EM; Nur MAM; Elussein EA; Elshafie A; Åkerud H; Rönnelid J Lupus; 2020 Apr; 29(5):463-473. PubMed ID: 32106789 [TBL] [Abstract][Full Text] [Related]
46. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. Kolyada A; Porter A; Beglova N Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078 [TBL] [Abstract][Full Text] [Related]
48. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Artenjak A; Locatelli I; Brelih H; Simonič DM; Ulcova-Gallova Z; Swadzba J; Musial J; Iwaniec T; Stojanovich L; Conti F; Valesini G; Avčin T; Cohen Tervaert JW; Shoenfeld Y; Blank M; Ambrožič A; Sodin-Semrl S; Božič B; Čučnik S Immunol Res; 2015 Feb; 61(1-2):35-44. PubMed ID: 25395339 [TBL] [Abstract][Full Text] [Related]
49. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434 [TBL] [Abstract][Full Text] [Related]
50. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Pengo V; Bison E; Ruffatti A; Iliceto S Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538 [TBL] [Abstract][Full Text] [Related]
51. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching. Oba S; Hosoya T; Kaneshige R; Kawata D; Yamaguchi T; Mitsumura T; Shimada S; Shibata S; Tateishi T; Koike R; Tohda S; Hirakawa A; Yoko N; Otomo Y; Nojima J; Miyazaki Y; Yasuda S Front Immunol; 2023; 14():1227547. PubMed ID: 37908357 [TBL] [Abstract][Full Text] [Related]
53. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome. Devreese KM Blood Coagul Fibrinolysis; 2006 Nov; 17(8):651-9. PubMed ID: 17102652 [TBL] [Abstract][Full Text] [Related]
55. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. Ofer-Shiber S; Molad Y Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601 [TBL] [Abstract][Full Text] [Related]
56. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Ostertag MV; Liu X; Henderson V; Pierangeli SS Lupus; 2006; 15(6):358-65. PubMed ID: 16830882 [TBL] [Abstract][Full Text] [Related]
57. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards. Cucurull E; Espinoza LR; Mendez E; Molina JF; Molina J; Ordi-Ros J; Gharavi AE Lupus; 1999; 8(2):134-41. PubMed ID: 10192508 [TBL] [Abstract][Full Text] [Related]
58. Assessment of diagnostic methods for the detection of anticardiolipin and anti-βeta Martins TB; Heikal N; Miller J; Willis R; Schmidt RL; Tebo AE Clin Chim Acta; 2018 Oct; 485():7-13. PubMed ID: 29883633 [TBL] [Abstract][Full Text] [Related]